1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Blood Bank Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Whole Blood
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Red Blood Cells
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Platelet
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Plasma
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 White Blood Cells
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Bank Type
7.1 Private
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Public
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Function
8.1 Collection
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Processing
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Testing
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Storage
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Transportation
8.5.1 Market Trends
8.5.2 Market Forecast
9 Market Breakup by End User
9.1 Hospital
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Ambulatory Surgery Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Clinics and Nursing Homes
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 American Association of Blood Banks
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Blood Bank of Alaska
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Canadian Blood Services
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Haemonetics Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Japanese Red Cross Society
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 New York Blood Center
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 NHS Blood and Transplant
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 Sanquin Bloedvoorziening
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Terumo Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 The American National Red Cross
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Vitalant
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer